Iteos Therapeutics, Inc. (ITOS)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

4

0

5

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
07-Dec-23 8:22 PM View:	05-Dec-23 Grant 0	Call Matthew Chief Operating Officer		Iteos Therapeutics, Inc. - ITOS	47% 93.9K to 137.9K	0	0	--	--	Show Txns Hide Txns

19-Nov-24 7:59 PM View:	19-Nov-24 Private Purchase $38.64K	Gall Matthew Chief Financial Officer		Iteos Therapeutics, Inc. - ITOS	237% 19.43K to 65.43K	0	0	--	--	Show Txns Hide Txns

07-Dec-23 8:20 PM View:	05-Dec-23 Grant 0	Detheux Michel Chief Executive Officer		Iteos Therapeutics, Inc. - ITOS	104% 28.9K to 58.9K	0	0	--	--	Show Txns Hide Txns

07-Dec-23 8:22 PM View:	05-Dec-23 Grant 0	McGrath Yvonne Chief Scientific Officer		Iteos Therapeutics, Inc. - ITOS	100% 0 to 31.0K	0	0	--	--	Show Txns Hide Txns

14-May-24 9:32 PM View:	10-May-24 Grant $20.00M	Boxer Capital, LLC		Iteos Therapeutics, Inc. - ITOS	63% 1.8M to 2.95M	0	0	--	--	Show Txns Hide Txns

14-May-24 9:06 PM View:	12-May-24 Disposition (other) 0	Ra Capital Management, LLC		Iteos Therapeutics, Inc. - ITOS	(20%) 4.42M to 3.52M	0	0	--	--	Show Txns Hide Txns